Written by Nick Ackerman, co-produced by Stanford Chemist Eaton Vance Tax-Advantaged Global Dividend Income Fund (NYSE:ETG) has been able to pull off some excellent returns for being a fund with a global focus, even while they have been overweight financials and increasing the exposure as well. Tech still appears in several

Introduction The iShares U.S. Medical Devices ETF (NYSEARCA:IHI) is a market-cap-weighted ETF that tracks an index of medical device manufacturers and medical devices in the US. The ETF charges a fee of 0.42% and has a little under $8 billion in assets under management. The fund has about 50 total holdings

Written by Nick Ackerman, co-produced by Stanford Chemist The Eaton Vance Enhanced Equity Income Fund II (EOS) has been on fire this year. This is thanks to its heavy weighting in tech. Led by a significant position in Amazon (AMZN). Eaton Vance runs a solid line-up of option-based funds. In this

Written by Nick Ackerman, co-produced by Stanford Chemist The Flaherty & Crumrine Preferred and Income Securities Fund (FFC) is currently trading around its average premium. This has come as the volatility of the last couple of weeks has brought the double-digit discount to a mid-single digit premium of 5.62%. Funds are

The Vanguard IT ETF (VGT) is up 23% YTD and 38% over the past year. It has been driven by a COVID-19 impacted market that has been rewarding the large-cap tech stocks for demonstrating excellent top- and bottom-line growth. This article will compare VGT with two leading technology ETFs and

As you can see in the following chart, the iPath S&P 500 Dynamic VIX ETN (XVZ) has somewhat surprisingly held its ground in the wake of the melt-up seen in the VIX earlier this year. In this article, I argue that while I believe XVZ has an above-average chance of

As you can see in the following chart, it's been a bit of a volatile year for the Credit Suisse Silver Shares Covered Call ETN (NASDAQ:SLVO) with shares seeing both substantial upside and downside throughout the course of this year's market turbulence. I believe that buying SLVO at these levels

The CEF market tends not to be the most efficient market due to the difficulty in obtaining quality data and the presence of low-information investors. This creates a number of opportunities for discerning investors to enter into attractive strategic positions or to make tactical allocations. In this article, we describe

Two months ago, I wrote a piece on Aris' RPAR Risk Parity ETF (RPAR). In it, I argued that the fund was "a great gateway approach to improve a portfolio's risk-adjusted return potential quickly and without frills", and that RPAR "could not only complement, but even replace equity-only investments altogether". Since

Today I continue my series of articles on dividend-oriented ETFs with a piece on WisdomTree U.S. High Dividend Fund (DHS). To begin with, I would like to highlight its low expense ratio of 0.38%, low volatility underpinned by a 60-months beta of only 0.88, a substantial standardized yield of 4.6%,